Bindukumari Sureshkumar Nandhini, Gopinath Prathima, Joshi Akanksha, Alumparambil Surendran Sreerag
Internal Medicine, Marshfield Clinic Health System, Marshfield, USA.
Critical Care, Icahn School of Medicine at Mount Sinai, New York, USA.
Cureus. 2022 Oct 10;14(10):e30149. doi: 10.7759/cureus.30149. eCollection 2022 Oct.
Lupus enteritis is a poorly studied cause of abdominal pain in patients with systemic lupus erythematosus (SLE). We present the case of a 28-year-old female with a history of SLE for nine years. She has been on chronic immunosuppressant therapy for the last nine years due to an episode of lupus enteritis in the past. Currently, the patient presented to urgent care with a three-day history of waxing and waning symptoms of abdominal pain, vomiting, and diarrhea. In addition, the patient had skin rashes. Laboratory work was significant for leukopenia, hypocomplementemia, hematuria, and proteinuria. CT of the abdomen showed bowel thickening involving the entire ileum, distal jejunum, and first portion of the duodenum. It was accompanied by moderate mesenteric edema and a small amount of ascites. Since the patient was on long-term immunosuppressive therapy with hydroxychloroquine and mycophenolate mofetil, infectious etiology was of high consideration; however, it was ruled out after further testing. Along with continuing her home dose of mycophenolate mofetil and hydroxychloroquine, the patient was started on IV methylprednisolone 1 mg/kg for three days. The patient dramatically responded to IV steroids. The patient was transitioned to oral prednisone 60 mg daily, and steroids were tapered off by 10 mg each week. A repeat CT scan in two months showed the resolution of the previously visualized small bowel wall thickening. This case highlights that chronic immunosuppression should not preclude differential or diagnosis of lupus enteritis in a patient with a history of SLE.
狼疮性肠炎是系统性红斑狼疮(SLE)患者腹痛的一个研究较少的病因。我们报告一例有9年SLE病史的28岁女性病例。由于过去曾患狼疮性肠炎,她在过去9年一直接受慢性免疫抑制治疗。目前,该患者因腹痛、呕吐和腹泻症状反复出现3天而前来急诊。此外,患者有皮疹。实验室检查显示白细胞减少、补体血症、血尿和蛋白尿。腹部CT显示整个回肠、空肠远端和十二指肠第一部分肠壁增厚。伴有中度肠系膜水肿和少量腹水。由于患者长期接受羟氯喹和霉酚酸酯免疫抑制治疗,感染性病因被高度怀疑;然而,进一步检查后排除了感染。在继续服用家中剂量的霉酚酸酯和羟氯喹的同时,患者开始静脉注射甲泼尼龙1mg/kg,共3天。患者对静脉注射类固醇有显著反应。患者转为每日口服泼尼松60mg,类固醇每周减量10mg。两个月后重复CT扫描显示之前可见的小肠壁增厚已消退。该病例强调,慢性免疫抑制不应排除对有SLE病史患者的狼疮性肠炎进行鉴别诊断。